|Videos|May 26, 2022
Drug Watch: What's Coming in Acne Treatment?
Author(s)Linda Stocum, Associate Editor
In this drug pipeline interview, Christopher Bunick, MD, PhD, discusses what is innovative in future acne treatment options, what research is happening, and what potential approvals the dermatology space has to look forward to.
Advertisement
Christopher Bunick, MD, PhD, Dermatology Times® editorial board member and physician-scientist practicing general medical and surgical dermatology at Yale University, in New Haven, Connecticut, dives into the acne drug pipeline. Hear his notes on what potenital new treatments are coming for acne vulgaris, exciting research advancements in the space, and much more.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Dermatology Times
1
Biologic Therapy Linked to Lower 10-Year MACE Risk Across Racial Groups in Psoriasis
2
Former CDC Director Robert Redfield Joins Turn Therapeutics as Chief Scientific Officer
3
Body Weight, Not BMI, Associated With Brodalumab Response Trajectory in Plaque Psoriasis
4
FDA Grants QRX003 Rare Pediatric Disease Designation in Peeling Skin Syndrome
5